Bluejay Diagnostics, Inc.
Market Cap
$857.19K
P/E Ratio
—
EPS
$657.48
Dividend Yield
0.00%
52-Week Range
$1.70 — $40.80
Volume
13.44K
Avg Volume
237.30K
Beta
0.72
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.00
P/B (TTM)
0.15
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.46%
ROA (TTM)
-0.96%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.02
Current Ratio
4.88
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.68%
EPS Growth (5Y)
-0.72%
Sales Growth (3Y)
-0.33%
Sales Growth (5Y)
-0.20%
EPS Est (This Year)
$-464.00
EPS Est (Next Year)
$-32.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$11.50
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
453.53K
Float
402.62K
Free Float %
88.77%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2021-11-10
Employees
7
CEO
Indranil Dey
Index Membership
—
Website
https://bluejaydx.com
Bluejay Diagnostics, Inc. (BJDX) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $857.19K, BJDX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BJDX against other stocks using dozens of fundamental and technical filters.
No, Bluejay Diagnostics, Inc. (BJDX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Bluejay Diagnostics, Inc. (BJDX) has a market capitalization of $857,192, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.